Objective: to assess the use of, knowledge about, and the demand for information concerning complementary and alternative medicine (CAM) in cancer patients. Methods: A cross-sectional survey was performed on consecutive patients visiting the outpatient tumor treatment center of a university hospital at Munich, Germany. The authors used a questionnaire with questions on sociodemographics, tumor diagnosis and treatment, current symptoms, previous use of CAM, and expectations and attitudes with respect to CAM. Results: 52% used at least 1 CAM method, 24% did not use CAM but asked for consultation, and 24% neither used CAM nor were interested; 59% rated CAM treatment as personally important; 76% and 34% described themselves as well informed about conventional treatment and CAM, respectively. Current CAM use was associated with higher degrees of information and subjective importance, and not suffering from lymphatic cancer and metastases. Conclusions: CAM is a relevant topic for the care of cancer patients.
recent review revealed no strong evidence that having cancer increases the likelihood of using CAM. 8 The reasons for cancer patients to opt for CAM treatment are dissatisfaction with conventional treatment because of side effects 9 but mainly focus on achievement of improved well-being while living with cancer. 10 Significant associations between CAM use and an active, problem-oriented coping style could be observed in cancer patients. 11 Furthermore, a strong belief in CAM, CAM as a last resort, or feeling hopeful about CAM are seen as common reasons for using it. 3 However, little is known about cancer patients who do not use CAM but would do so if clear information about CAM and its safety alongside with conventional treatment could be available and if CAM were offered to them.
The interdisciplinary outpatient cancer treatment center of our university hospital covers all essential medical specialties to facilitate optimal cancer care for patients and is frequented by about 40 patients per day. Since 2003, the Centre for Complementary Medicine Research is an integral part of this institution. For half a day per week, we offer consultation hours for patients referred from diverse departments of the hospital or from private practices. The main reason for the consultations is to Background Cancer patients report rates of complementary and alternative medicine (CAM) use ranging from 5% to more than 90%. [1] [2] [3] A systematic review of 26 studies from different countries confirms this broad range, with a median prevalence of 31% for all surveys. 4 This range is partly a result of the wide variation in CAM definition, scope, target population, sampling strategies, and analytical methods used in the surveys. CAM is mostly used as a complement, not an alternative, to conventional medicine. Internationally, biological-based therapies like herbs, vitamins/minerals, or medicinal teas are used most often followed by mind-body interventions. [5] [6] [7] However, a advise patients on appropriate CAM methods additional to conventional cancer treatment.
To improve our consulting service to cancer patients we desired to know more about the use of, knowledge about, and demand for information concerning complementary and alternative methods. The following questions were of special interest:
• How many patients wish for advisory service?
• Do patients rate themselves as informed about conventional treatment and CAM? • What do patients expect from CAM treatment? • Which complaints do patients suffer from that might be relieved by CAM? • How many patients already use CAM treatment?
• Which variables are able to predict CAM use and the demand for information, respectively? • Are there subgroups of patients with enhanced homogeneity?
Methods
We performed a cross-sectional survey on consecutive patients visiting the tumor treatment center of our hospital. Between November 2005 and January 2006, patients were recruited on 20 arbitrarily selected days, which were, however, controlled for different work days. They were approached by a member of our medical staff while sitting in an open room waiting for their appointment.
Patients were eligible if a cancer diagnosis was already known, if there was no previous contact with our CAM unit, and if language skills were sufficient to understand the questionnaire. Eligible patients were asked to give written consent after being informed on the purpose and contents of the survey. If patients were not willing to participate, the reasons for rejection were documented. The 4-page questionnaire was specially developed for this study and comprised questions on sociodemographics, tumor diagnosis and treatment, current symptoms (predefined list of 28 symptoms with 5 answer categories from 0 = not at all to 4 = very strong summed up to a total symptom score ranging from 0 to 112 points), previous use of CAM, and expectations and attitudes with respect to CAM. The study was approved by the local institutional review board.
Statistical analysis was primarily designed as descriptive. Differences between subgroups of patients were exploratively tested by χ 2 tests and 1-way analyses of variance. Logistic regression analyses were performed to identify predictors for binary dependent variables. Odds ratios were estimated for all the variables in the model. A 2-step cluster analysis was administered to reveal natural groupings within a data set allowing continuous and categorical data simultaneously. The optimal number of clusters was determined according to the Bayesian information criterion. All data were analyzed using statistical software SPSS version 15.0. 12 Prior to regression and cluster analyses, missing values (maximum was <7% per variable) were imputed by the expectation-maximization algorithm, which estimates missing data using an iterative maximum-likelihood procedure. It is one of the recommended methods for preventing biases caused by not-completely-random missing data processes. 13 The imputation was performed with the software NORM. 14 Out of the 240 patients contacted, 199 fulfilled the inclusion criteria. The main reason for exclusion (19 patients) was that a cancer diagnosis was not yet confirmed ( Figure 1 ). Of the eligible participants, 43 (21.6%) refused to participate. Most patients declared that they were not interested in filling (n = 16) or did not have the time to fill in (n = 12) the questionnaire. The remaining 156 participants were included in the analysis.
Results
Patients in the sample (37.8% female) had a mean age of 60.1 (SD = 12.9) years ( Table 1) . For the majority, cancer diagnosis had been made more than 1 year earlier. The mean time since diagnosis was about 3 years, with a maximum of about 20 years. The most frequent tumors were related to the gastrointestinal system (20.8%), breast, and lymphatic organs (17.5% each), and 37.2% of the patients were affected by metastases. Patients rated their general health status as good or rather good in 61.3% of the cases, whereas a percentage of 13.5% judged their current health as bad or rather bad. No cancer diagnosis (19) Accompanying person (8) Already treated by CAM unit (5) No German language (4) Previously interviewed (3) Previously rejected (2) No interest (16) No time (12) Feeling too weak (5) Questionnaire not returned (4) Other reasons (10) Conventional tumor treatment was given to 48.1% during the preceding 3 months, mainly in form of chemotherapy (27%) or radiation (19%). In 28% treatment was intended to be continued ( Table 2 ). In all, 51.9% reported current CAM use or reported using it in the preceding 3 months. The most frequent modalities were diet (39.7%), dietary supplements (27.6%), and physical exercise (27.6%). All other CAM methods were used by less than 10% of the patients ( Table 2) . With respect to the combination of conventional and CAM treatment, a quartering of the sample could be observed. About 25% received neither conventional nor CAM treatment, another quarter got both, and the remaining two quarters were treated by only one of these forms each.
Whereas most patients described themselves as well informed about conventional cancer therapies (76% well/very well), there was a smaller portion of patients with similar appraisal concerning CAM therapies (34%). Here, more patients designated their level of being informed as poor or very poor (44%; Table 3 ). Both assessments are positively correlated (r = .22), indicating a common concept of information. A proportion of 48% definitely demanded CAM consultation irrespective of whether they already used CAM or not. Another analysis revealed that 24% of the patients neither used CAM nor were interested in corresponding consultation, 24% did not use CAM but now requested information on this field, and the remaining 52% were CAM users anyway; 59% of the patients rated CAM treatment as important with respect to their own cancer treatment. "Improving quality of life" (48%), "boosting the immune system" (41%), and "relief of side effects" (37%) were expected as the main benefits of such a therapeutic approach (Table 3) .
Whereas the majority of patients (86%) reported at least 1 symptom in moderate or higher intensity, only 27% would expect symptom relief under CAM treatment. On average, the most distinctive symptoms were fatigue (mean rating 1.1), sleep disorders (1.0), and back pain/headache (1.0). A mean number of 9 symptoms per patient (of which 7 in slight/moderate intensity and 2 in strong/very strong intensity) were reported. With regard to CAM use and demand for CAM consultation, respectively, the subgroups showed similar patterns of symptom prevalence with 1 marked exception: patients without previous CAM use but with interest in CAM consultation showed a more than doubled prevalence of susceptibility to infections compared with the other 2 subgroups ( Figure 2 ). Logistic regression analysis showed that 4 predictors were included stepwise into the model when predicting the dependent variable "current CAM use" (yes/no). No other variable contributed to a statistically significant increase of prediction (Table 4 ). "Degree of being informed about CAM" and "subjective importance of CAM" were positively associated with CAM use, whereas "metastases" and the diagnosis "lymphatic cancer" were associated with CAM use "no" (weights < 0); 44% of total variance was explained by these 4 predictors.
To predict "demand for CAM consultation" (yes/no), 6 predictor variables were included into the regression model, which covered 42% of total variance. "Subjective importance of CAM" coincided positively with the dependent variable, whereas the negative weights of all other predictors indicated that being less informed about CAM or conventional treatment, being younger, having poorer health status, and not having gastrointestinal cancer increased the likelihood of being interested in CAM consultation (Table 4 ).
Cluster analysis resulted in a 3-cluster solution, which can be described as follows (Table 5) : cluster 3 with 29 patients comprised only women with breast cancer in the majority (90%). These patients demonstrated a higher level of information on cancer treatment (especially with respect to CAM), a more pronounced prevalence of CAM use (69%), and less interest in CAM consultation (not significant). Cluster 1 summarized 63 patients in the situation prior to conventional cancer therapy (59%), with worse health status and showing more symptoms, with lower prevalence of CAM use (41%), but with more frequent demand for CAM consultation (59%). In contrast to this, patients of cluster 2 (64 patients) showed less interest in CAM consultation (44%), an average rate of CAM use (55%), and a better health status, with a smaller symptom score compared with the other 2 subgroups. Nearly all patients were in the status after conventional cancer treatment.
Discussion
Our survey in patients of an interdisciplinary cancer treatment center revealed an overall prevalence of current CAM use of 52%; 24% did not use CAM but reported the demand for consultation, and only 24% neither used CAM nor were interested in corresponding consultation. Only one third of our patients rated themselves as well informed. This is noteworthy because there is a huge amount of information on CAM available for cancer patients in print media, the Internet, and from patient organizations.
With respect to the single CAM methods, patients reported diet as the most frequently used method (40%). Patients may think here not only of a medical intervention but more of changes in everyday eating behavior. The prevalence of herb intake was astonishingly low (4%), but this has to be seen in the context of other categories like dietary supplements (28%), intake of mistletoe, thymus or factor AF-2 (6%), and homeopathy or anthroposophic remedies (6%), with a broad overlap in patients' understanding.
In general, our survey indicated less use of CAM methods compared with more recent results from the literature. For example, a sample of 356 patients with different cancer diagnoses showed a rate of CAM use of 70%, 15 and it was 83% in an outpatient sample of 453 patients. 16 These differing findings beg the question of to what degree our participants are representative. First of all, the response rate of nearly 80% was quite high, and the reasons for declining were well documented. Second, it is assumed that the population of patients visiting the interdisciplinary cancer treatment center of our university hospital is different from that at a unit of cancer care that is known to offer CAM, alone or in combination with conventional methods. Unlike other surveys on CAM use, we asked the patients to report current symptoms and complaints. The most frequent symptoms like pain, fatigue, sleep disorders, or freezing are suspected to be mostly induced by the disease itself or by conventional tumor treatment and may be successfully treated by simple CAM methods like exercise, relaxation, herbal drugs, hydrotherapy, or acupuncture. Patients who did not yet use CAM but asked for more information about CAM reported "susceptibility to infections" significantly more often than the other patients. This symptom seems to be the key complaint to induce the demand for CAM consultation.
Regression analyses revealed satisfactory rates of explained variance (about 40%). However, none of the variables suspected as predictors of current CAM use showed statistically significant associations but only more or less trivial relationships with the degree of information or the subjective importance of CAM. Accordingly, the demand for CAM consultation was also associated with the attributed importance but, on the other hand, related with being less informed about CAM. Clinical experience with cancer patients, however, often shows that patients with profound knowledge still wish to learn much more about CAM.
Subgroup analysis was suitable to better describe the heterogeneous patient sample. One homogeneous group was represented by almost all breast cancer patients. Compared with the other groups, most of these patients were already familiar with CAM, which means that advisory service should be offered especially to cancer patients not having breast cancer. The crucial criterion to define the other 2 subgroups was to be situated before or after conventional tumor treatment. Patients with planned cancer treatment showed lowest CAM use but highest demand for consultation. Accordingly, time since cancer diagnosis, health status, and number of symptoms was significantly different. Clinical experience with patients of our CAM unit shows that patients before or during their conventional treatment primarily seek additional help to relieve therapy-related symptoms and Figure 2 . Frequency of patients currently suffering from diverse symptoms in moderate to very strong intensity (decreasing order) with respect to 3 subgroups: no current use of CAM/no demand for information (n = 38, solid line); no current use of CAM but demand for information (n = 37, dashed line); current use of CAM (n = 81, dotted line). adverse effects (eg, nausea, vomiting, fatigue). After completing conventional therapy, the main reason for CAM consultation is to prevent relapse of the tumor.
Our survey was a cross-sectional study representing not more than a snapshot of the current situation of the patients. Only a longitudinal description of the dynamic processes will NOTES: CAM = complementary and alternative medicine; SE = standard error; df = degrees of freedom; OR = odds ratio; CI = confidence interval a For the list of all potential predictor variables being considered for regression analysis, see Table 5 . b Conventional cancer treatment. 
Conclusions
Our survey clearly indicated that for the majority of cancer patients, CAM is a relevant topic for their cancer care, and an appropriate facility should be available within a specialized cancer treatment center to offer information and advice about CAM to meet the patients' demands. Dependent on the individual position in the course of care, CAM consultation should always be guided by the basic questions for expected benefits and risks-whether benefits outweigh the risks and whether CAM therapy interferes with conventional treatment.
